The Use of Workflows in the Design and Implementation of Complex Experiments in Macromolecular Crystallography
Tuesday, September 11, 2012
This article highlights how implementation of a Data Analysis WorkBench should allow new protocols to be developed quickly and easily in response to the growing demands within structural biology.
Characterization of Aptamer-Protein Complexes by X-ray Crystallography and Alternative Approaches
Tuesday, September 11, 2012
In this review, researchers from Wageningen University describe the relevant technical issues and difficulties in the process of crystallizing aptamer-protein complexes.
Studying the Structure of Drug Resistance in TB
Wednesday, August 29, 2012
Researchers at Iowa State and Ames Laboratory have used X-ray crystallography to study the structure of the tuberculosis efflux pump regulator.
Facilities for Macromolecular Crystallography at the Helmholtz-Zentrum Berlin
Wednesday, August 29, 2012
Three macromolecular crystallography beamlines at the Helmholtz-Zentrum Berlin are available for the regional, national and international structural biology user community.
X-Ray Crystallography: Assessment and Validation of Protein Small Molecule Complexes for Drug Discovery
Wednesday, August 29, 2012
This review discusses how to evaluate the correctness of an X-ray structure, focusing on the validation of small molecule-protein complexes.
Agilent Technologies Reports Third-Quarter 2012 Results
Thursday, August 16, 2012
Revenues were $1.72 billion for the third fiscal quarter ended July 31, 2012, 2 percent above one year ago.
Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease
Tuesday, August 14, 2012
Researchers have utilized X-ray crystallography to demonstrate how these inhibitors coordinate the two-metal endonuclease active site and engage the active site residues.
Proteros Announces Successful Close of Financing Round
Tuesday, August 07, 2012
Largest-ever financing allows for expansion of drug discovery capabilities.
BioCryst Provides Second Quarter 2012 Financial Results
Friday, August 03, 2012
For the six months ended June 30, 2012, total revenues increased to $16.4 million from $9.2 million in the first half of 2011.
|
|
|
|
|
|
